Trial intelligence / Profile preview

Amodiaquine vs Amodiaquine + Artesunate for Uncomplicated P. Falciparum Malaria

NCT00378625Phase 3Completed

Sponsor
CIDEIM
Start
Apr 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of artesunate in Malaria, sponsored by CIDEIM. Started Apr 2000; status: completed.

02

Drugs

artesunate
03

Conditions

Malaria

Beyond the preview

Go deeper on NCT00378625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00378625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call